Skip to main content
. 2022 Mar 21;28(4):735–742. doi: 10.1038/s41591-022-01731-4

Fig. 2. Forest plot representing subgroup analyses of CRR in patients included in primary efficacy analysis.

Fig. 2

Response assessments, according to Lugano classification30, are displayed regarding CRR for subgroups of interest within the efficacy-evaluable population (n = 37). Data for each group are presented as the proportion of patients with CR and 95% CI (based on the Clopper–Pearson method). Dashed vertical line represents the point estimate of the overall population.